|
PRKAG1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.422600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.138000E-02 |
| Normal-vs-Stage2 |
6.835800E-01 |
| Normal-vs-Stage3 |
5.662000E-01 |
| Normal-vs-Stage4 |
3.043000E-01 |
| Stage1-vs-Stage2 |
5.843000E-01 |
| Stage1-vs-Stage3 |
6.367600E-01 |
| Stage1-vs-Stage4 |
7.945600E-02 |
| Stage2-vs-Stage3 |
9.004600E-01 |
| Stage2-vs-Stage4 |
1.941160E-01 |
| Stage3-vs-Stage4 |
1.726610E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.856640E-01 |
| Normal-vs-AfricanAmerican |
9.810400E-01 |
| Normal-vs-Asian |
9.631000E-01 |
| Caucasian-vs-AfricanAmerican |
2.839400E-01 |
| Caucasian-vs-Asian |
7.860400E-01 |
| AfricanAmerican-vs-Asian |
9.544000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.562100E-02 |
| Normal-vs-Female |
1.782370E-01 |
| Male-vs-Female |
2.201400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.173000E-01 |
| Normal-vs-Extreme_Weight |
6.040200E-02 |
| Normal-vs-Obese |
3.205000E-01 |
| Normal-vs-Extreme_Obese |
3.391800E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.367000E-01 |
| Normal_Weight-vs-Obese |
7.724600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.222650E-01 |
| Extreme_Weight-vs-Obese |
4.175400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.664400E-01 |
| Obese-vs-Extreme_Obese |
1.183000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.570830E-01 |
| Normal-vs-Age(41-60Yrs) |
9.663400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.228300E-02 |
| Normal-vs-Age(81-100Yrs) |
3.382600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.519850E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.356480E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.200300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.872200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.365000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.823000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.775600E-02 |
| Normal-VS-Type2 PRCC |
5.518400E-01 |
| Normal-VS-KIRP CIMP |
9.089600E-01 |
| Normal-VS-Unclassified PRCC |
5.347400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.538600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.635400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.553820E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.100000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.132000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.122000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.657900E-02 |
| Normal-vs-N1 |
7.205800E-01 |
| Normal-vs-N2 |
3.990400E-01 |
| N0-vs-N1 |
1.143030E-01 |
| N0-vs-N2 |
5.656100E-02 |
| N1-vs-N2 |
3.391200E-01 |
|
|
